Related Experiment Video
Updated: Mar 1, 2026

08:43
Fused Filament Fabrication FFF of Metal-Ceramic Components
Published on: January 11, 2019
18.2K
RTD modeling of a continuous dry granulation process for process control and materials diversion
Julia Kruisz1, Jakob Rehrl2, Stephan Sacher1
1Research Center Pharmaceutical Engineering GmbH, Graz, Austria.
International Journal of Pharmaceutics
|June 7, 2017
Summary
Residence time distribution (RTD) modeling predicts disturbance propagation in continuous manufacturing. This study developed RTD models for dry granulation, enabling better process control and waste reduction.
Area of Science:
- Chemical Engineering
- Pharmaceutical Manufacturing
- Process Systems Engineering
Background:
- Continuous manufacturing processes require robust monitoring to predict and mitigate disturbance propagation.
- Residence Time Distribution (RTD) is a key parameter for understanding material flow and variability in unit operations.
Purpose of the Study:
- To develop and apply RTD models for a dry granulation process in continuous manufacturing.
- To assess the impact of feeding events on disturbance propagation and waste generation.
- To provide a foundation for a control concept in pharmaceutical manufacturing.
Main Methods:
- Impulse-response measurements using color tracers to characterize feeders.
- Development of RTD models for the blender and roller compactor units.
- Simulation of four feeding event scenarios to analyze disturbance propagation.
- Definition of out-of-specification material based on active pharmaceutical ingredient (API) concentration.
Main Results:
- RTD models were successfully developed for key unit operations in dry granulation.
- Simulations quantified waste material under various process upset scenarios.
- The study demonstrated the capability of RTD models for material tracking and contaminant spread analysis.
- Effective identification of waste material at diversion points was achieved.
Conclusions:
- RTD modeling is a valuable tool for pharmaceutical continuous manufacturing process development and design.
- RTD models facilitate effective process monitoring and material tracking.
- The developed approach aids in minimizing waste and ensuring product quality by predicting disturbance propagation.
More Related Videos
Related Concept Videos
Design Example: Aggregate Gradation
353
The right type and quality of aggregates are crucial for concrete as they significantly influence its properties, mix proportions, and cost-effectiveness. If different sources are available for sand, the commonly used fine aggregate in concrete, the selection of sand is primarily based on its gradation.
The grading, or particle-size distribution, of sand is determined using sieve analysis, with standard sizes ranging from 150 μm to 10 mm (ASTM No. 100 sieve to 3⁄8 in. sieve). Sand is...
The grading, or particle-size distribution, of sand is determined using sieve analysis, with standard sizes ranging from 150 μm to 10 mm (ASTM No. 100 sieve to 3⁄8 in. sieve). Sand is...
353
Precipitate Formation and Particle Size Control
6.9K
In precipitation gravimetry, the precipitating agent should react specifically or selectively with the analyte. While a specific reagent reacts with the analyte alone, a selective reagent can react with a limited number of chemical species.
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
The obtained precipitate should be either a pure substance of known composition or easily converted to one by a simple process, such as ignition or drying. In addition, the precipitate should be insoluble and easily filterable. In general, filterability...
6.9K
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
382
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
382

